Elisabeta Gherga
Centre Hospitalier Universitaire de Besançon(FR)L'Hôpital Nord Franche-Comté(FR)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Head and Neck Surgical Oncology, Glioma Diagnosis and Treatment, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study(2020)126 cited
- → Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial(2023)51 cited
- → Approach to Oligometastatic Disease in Head and Neck Cancer, on Behalf of the GORTEC(2018)38 cited
- → PET-based prognostic survival model after radiotherapy for head and neck cancer(2018)24 cited
- → FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study(2020)17 cited
- → Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases(2020)12 cited
- → 914MO Standard versus fractionated high dose cisplatin concomitant with radiotherapy in locally advanced head & neck squamous cell cancer (LA-HNSCC): Results of the GORTEC 2015-02 CisFRad randomized trial(2020)8 cited
- → Anti-telomerase vaccine in patients with newly diagnosed, unmethylated MGMT glioblastoma: A phase II study.(2023)7 cited
- → Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial(2024)5 cited
- → KS01.6.A UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM(2023)3 cited